We are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of astrointestinal,or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Lead Underwriter
Citigroup Global Markets Inc,Cowen and Company, LLC
Co-Managers
Canaccord Genuity Inc,Cantor Fitzgerald and Co,Oppenheimer and Co., Inc.